Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>Marta Milà‐Alomà, Karine Fauria, José María Gónzalez‐de‐Echávarri et al.|Alzheimer s & Dementia|2020Cited by 260